Petrovax maintains high standards of relationship culture both in-house and with partners. An elaborate algorithm of communication made it possible for the company to maintain its impeccable reputation for 20 years, and stay up as the industry leader.
Petrovax successfully hits the industry’s priority targets significantly boosting growth of the local products market share, implementing technological innovations, performing the import substitution program and developing international projects. Petrovax ’s strategy is fully in line with the macroeconomic trends. The company continues developing rapidly expanding its product range, and geographic footprint.
Presently, the company successfully contends with world leaders both on the domestic and foreign market, exports medicines to the countries of EEU, Middle East (Iran) and EU (Slovakia).
Petrovax has significant experience in implementing international projects on the transfer advanced technologies of the full cycle of production, control and quality assurance of the final product in partnership with Pfizer, Abbott, Boehringer Ingelheim.
Petrovax is one of the few Russian companies creating pharmaceuticals «from scratch». This process is driven by the facility boasting a many-year experience of immunobiologicals manufacturing to GMP standards.
In the modern context, there is high demand for elaborate in-house communications as well as continuous personnel training, and skill improvement to change with the times. It would have been impossible to achieve Petrovax ’s ambitious objectives without teamwork synergy, corporate spirit, and ability to generate and implement ideas.
The company is set apart for its continuous personnel training efforts, and maintaining high competence level facilitating integration in large-scale projects. Petrovax has created conditions for gaining professional experience and opportunities for further career development.